Vifor Pharma: STAT+: European Commission reaches deal with Vifor for 'disparaging' its only rival in iron deficiency market
The European Commission has reached a deal with Vifor Pharma after it was accused of disparaging its only rival in the iron deficiency market.
Read full article »
Vifor Pharma is a Switzerland-based pharmaceutical company that develops nephrology and cardio-renal therapies for the treatment of heart failure and kidney diseases.
Read more